Jubilant Ingrevia Limited — Important, 05-02-2026: Updates

Jubilant Ingrevia reported Q3 revenue of ₹1,051 Cr and PAT of ₹47 Cr, affected by pricing. Strong volume growth in Specialty Chemicals & Nutrition maintained stability. 9M'FY26 revenue rose 3%, EBITDA 8%. A major CDMO order delivery & new multipurpose plant are on track. Interim dividend ₹2.5/share declared. Net debt cut 20% to ₹544 Cr.